Keyphrases
Mycosis Fungoides
100%
Psoriasis
25%
Pemphigus
23%
Cutaneous T-cell Lymphoma
23%
Cutaneous Lymphoma
21%
Meta-analysis
20%
Systematic Meta-analysis
20%
Systematic Literature Review
13%
Israel
13%
Adverse Effects
12%
Hidradenitis Suppurativa
12%
Rituximab
11%
Atopic Dermatitis
11%
Kaposi Sarcoma
10%
Plaque
10%
Sézary Syndrome
9%
Bullous Pemphigoid
9%
Real-world Experience
9%
Pediatric
9%
Chlormethine Gel
8%
EORTC
8%
Retrospective Cohort Study
8%
Etretinate
8%
Primary Anetoderma
8%
Tertiary Care Hospital
8%
Non-melanoma Skin Cancer
7%
Epidermis
7%
Phototherapy
7%
Confidence Interval
7%
Clinical Features
7%
Advanced Stage
6%
Solid Organ Transplant Recipients
6%
Primary Cutaneous B-cell Lymphoma
6%
Single-center Experience
6%
MicroRNA-155 (miR-155)
6%
Pemphigus Vulgaris
6%
Israeli
6%
Erythropoietic Protoporphyria
6%
Acne
6%
Complete Response
6%
Monotherapy
6%
Adverse Events
6%
Scalp
5%
Folliculotropic
5%
Climatotherapy
5%
Dead Sea Climatotherapy
5%
Omalizumab
5%
Ultraviolet-B (UV-B)
5%
Tumor
5%
Remission
5%
Medicine and Dentistry
Mycosis fungoides
89%
Disease
30%
Systematic Review
29%
Cutaneous Lymphoma
23%
Psoriasis
20%
Cutaneous T Cell Lymphoma
18%
Meta-Analysis
18%
Adverse Event
16%
Pemphigus
15%
Neoplasm
14%
Pediatrics
13%
Retrospective Cohort Study
11%
Atopic Dermatitis
9%
Transplantation
9%
Anetoderma
8%
Kaposi Sarcoma
8%
B-Cell Lymphoma
8%
Symptom
8%
Side Effect
8%
Dermatology
8%
Basal-Cell Carcinoma
8%
Sezary Syndrome
8%
Non Melanoma Skin Cancer
7%
Cancer
7%
Phototherapy
7%
Climatotherapy
7%
Keratinocyte
7%
Retrospective Study
7%
Hidradenitis Suppurativa
6%
Bullous Pemphigoid
6%
microRNA 155
6%
Etretinate
6%
Prevalence
6%
Cohort Analysis
6%
Scalp
6%
Retinoid
5%
Skin Defect
5%
Biological Product
5%
Low Level Laser Therapy
5%
Immunofluorescence
5%
Psoralen
5%
Biopsy
5%
Programmed Cell Death
5%
T Cell
5%
Actinic Keratosis
5%
Systemic Therapy
5%
Solar Urticaria
5%
Antiphospholipid Antibody
5%
International Prognostic Index
5%
Cytokine
5%